(Q34533164)

2 August 2017

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer (English)

1 reference

nucleic acid sequence analysis

2 August 2017

0 references

1 reference

25

Bert Vogelstein

0 references

Lu Li

Lu Li

4

0 references

Cristian Tomasetti

Cristian Tomasetti

3

0 references

Rachel Wong

Rachel Wong

13

0 references

Jayesh Desai

Jayesh Desai

16

0 references

Luis Alberto Diaz Jr

Luis A Diaz

22

0 references

Kenneth W. Kinzler

24

Kenneth W Kinzler

1 reference

2 August 2017

5

Simeon Springer

1 reference

2 August 2017

Nickolas Papadopoulos

23

Nickolas Papadopoulos

1 reference

2 August 2017

21

Robert L Strausberg

1 reference

2 August 2017

7

Natalie Silliman

1 reference

2 August 2017

6

Isaac Kinde

1 reference

2 August 2017

1

Jeanne Tie

1 reference

2 August 2017

11

Suzanne Kosmider

1 reference

2 August 2017

26

Peter Gibbs

1 reference

2 August 2017

Yuxuan Wang

2

1 reference

2 August 2017

Mark Tacey

8

1 reference

2 August 2017

Hui-Li Wong

9

1 reference

2 August 2017

Michael Christie

10

1 reference

2 August 2017

Iain Skinner

12

1 reference

2 August 2017

Malcolm Steel

14

1 reference

2 August 2017

Ben Tran

15

1 reference

2 August 2017

Ian Jones

17

1 reference

2 August 2017

Andrew Haydon

18

1 reference

2 August 2017

Theresa Hayes

19

1 reference

2 August 2017

Tim J Price

20

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2016

1 reference

Science Translational Medicine

2 August 2017

1 reference

2 August 2017

8

1 reference

2 August 2017

346

1 reference

2 August 2017

346ra92

1 reference

Integrated digital error suppression for improved detection of circulating tumor DNA

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Detection of circulating tumor DNA in early- and late-stage human malignancies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Evolutionary dynamics of cancer in response to targeted combination therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Comprehensive molecular characterization of human colon and rectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Detection and quantification of rare mutations with massively parallel sequencing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Circulating mutant DNA to assess tumor dynamics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

The genomic landscapes of human breast and colorectal cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Time-dependent ROC curves for censored survival data and a diagnostic marker

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346159

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

7 July 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF6219

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF6219

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF6219

Follow-up strategies for patients treated for non-metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF6219

Identification of patients with high-risk stage II colon cancer for adjuvant therapy

21 January 2018

1 reference

12 December 2020

Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer

1 reference

12 December 2020

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

12 December 2020

2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines

1 reference

12 December 2020

10.1126/SCITRANSLMED.AAF6219

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference